MUSC Hollings Cancer Center is a clinical research site located in Charleston, South Carolina, United States 29425.
Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.
MUSC Hollings Cancer Center has participated in 25 clinical trials with 6 currently active.
Therapeutic areas: Renal Cell Carcinoma, Chemotherapy-Induced Nausea and Vomiting, Breast Cancer.
Sponsors: Hoosier Cancer Research Network, Lawrence Einhorn, Stemline Therapeutics, Inc..
Trust Score: 83/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
MUSC Hollings Cancer Center has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
MUSC Hollings Cancer Center has 25 clinical trials on record, with 6 currently active. Their work covers Renal Cell Carcinoma, Chemotherapy-Induced Nausea and Vomiting, Breast Cancer.
MUSC Hollings Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.